Výsledky vyhledávání - "Donato di Paola, E"

Akademický článek

It's time for chronotherapy!

Autor: Coudert, B, Focan, C, Donato di Paola, E, Lévi, F

Publikováno v: In European Journal of Cancer 2002 38 Supplement 4:50-53

Zobrazit plný text záznamu

Akademický článek

The EORTC Soft Tissue and Bone Sarcoma Group

Autor: Donato Di Paola, E, Nielsen, O.S

Publikováno v: In European Journal of Cancer 2002 38 Supplement 4:138-141

Zobrazit plný text záznamu

Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice

Autor: Russo E, Donato di Paola E, Gareri P, Siniscalchi A, Labate A, Gallelli L, Citraro R, De Sarro G.

Publikováno v: Pharmacological research (Online) 70 (2013): 1–12.
info:cnr-pdr/source/autori:Russo E, Donato di Paola E, Gareri P, Siniscalchi A, Labate A, Gallelli L, Citraro R, De Sarro G./titolo:Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA%2F2 mice./doi:/rivista:Pharmacological research (Online)/anno:2013/pagina_da:1/pagina_a:12/intervallo_pagine:1–12/volume:70

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::11326832778323a6c5f4acd836477708
https://publications.cnr.it/doc/208320

Zobrazit plný text záznamu

Update of the Imatinib (STI571, Glivec) phase I study in gastro intestinal stromal tumours (GISTs)

Autor: T. van Oosterom, A., Judson, I., Verweij, J., Donato di Paola, E., Dimitrijevic, S., Dumez, H., Scurr, M., Sciot, R., Silberman, S., van Glabbeke, M., Nielsen, Ole Steen

Publikováno v: T. van Oosterom, A, Judson, I, Verweij, J, Donato di Paola, E, Dimitrijevic, S, Dumez, H, Scurr, M, Sciot, R, Silberman, S, van Glabbeke, M & Nielsen, O S 2002, ' Update of the Imatinib (STI571, Glivec) phase I study in gastro intestinal stromal tumours (GISTs). ', Journal of Clinical Oncology .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::c47d1dc44dfe433237ff1db17b9702f2
https://pure.au.dk/portal/da/publications/update-of-the-imatinib-sti571-glivec-phase-i-study-in-gastro-intestinal-stromal-tumours-gists(4d5af69c-5198-4082-8000-c24d9328b59c).html

Zobrazit plný text záznamu

Imatinib (Gleeved) an active agent for gastrointestinal stromal tumours (GIST) but not for other soft tissue sarcoma (STS) subtypes not characterized for KIT and PDGF-R expression. Results of EORTC Phase II studies

Autor: Judson, I., Verweij, J., van Oosterom, A., Blay, J-Y., Rodenhuis, S., van der Graaf, W., Radford, J. A., Le Cesne, A., Hogendoorn, P., Donato di Paola, E., Brown, M., Dimitrijevic, S., Nielsen, Ole Steen

Publikováno v: Judson, I, Verweij, J, van Oosterom, A, Blay, J-Y, Rodenhuis, S, van der Graaf, W, Radford, J A, Le Cesne, A, Hogendoorn, P, Donato di Paola, E, Brown, M, Dimitrijevic, S & Nielsen, O S 2002, ' Imatinib (Gleeved) an active agent for gastrointestinal stromal tumours (GIST) but not for other soft tissue sarcoma (STS) subtypes not characterized for KIT and PDGF-R expression. Results of EORTC Phase II studies. ', Journal of Clinical Oncology .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::141aad421a12d85f27fa28d6b8914fb4
https://pure.au.dk/portal/da/publications/imatinib-gleeved-an-active-agent-for-gastrointestinal-stromal-tumours-gist-but-not-for-other-soft-tissue-sarcoma-sts-subtypes-not-characterized-for-kit-and-pdgfr-expression-results-of-eortc-phase-ii-studies(bf0e0cc5-034c-4b58-a215-4fd7ee53861e).html

Zobrazit plný text záznamu

A randomized phase II trial of caelyx/doxil versus doxorubicin in advanced or metastatic soft tissue sarcomas - an EORTC Soft Tissue and Bone Sarcoma Group trial

Autor: Judson, I., Radford, J., Blay, J-Y., van Hoesel, Q., le Cesne, A., van Oosterom, A. T., Nielsen, Ole Steen, Kamby, C., Woll, P., Harris, M., Hermans, C., Donato di Paola, E., Verweij, J.

Publikováno v: Judson, I, Radford, J, Blay, J-Y, van Hoesel, Q, le Cesne, A, van Oosterom, A T, Nielsen, O S, Kamby, C, Woll, P, Harris, M, Hermans, C, Donato di Paola, E & Verweij, J 1999, ' A randomized phase II trial of caelyx/doxil versus doxorubicin in advanced or metastatic soft tissue sarcomas-an EORTC Soft Tissue and Bone Sarcoma Group trial. ', Journal of Clinical Oncology .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::a3e3df36934fa1da2a08d42ac29bff29
https://pure.au.dk/portal/da/publications/a-randomized-phase-ii-trial-of-caelyxdoxil-versus-doxorubicin-in-advanced-or-metastatic-soft-tissue-sarcomas--an-eortc-soft-tissue-and-bone-sarcoma-group-trial(bfbd4054-abc8-4c0e-977b-043a80acea95).html

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání